What is the appropriate intramuscular dose of ceftriaxone (Rocephin) for a patient weighing 16.42 kg?

Rocephin IM Dose for 16.42 kg Patient

For a pediatric patient weighing 16.42 kg, administer ceftriaxone 50-75 mg/kg intramuscularly once daily, which translates to 821-1,231 mg (0.8-1.2 grams) depending on the infection severity, with a maximum daily dose not exceeding 2 grams.

Dosing Algorithm by Indication

The FDA-approved dosing for pediatric patients varies by infection type 111:

Standard Infections (Skin/Soft Tissue)

• Dose: 50-75 mg/kg once daily
• For 16.42 kg: 821-1,231 mg IM once daily
• Maximum: 2 grams/day
• Can be divided into twice-daily dosing if preferred

Acute Otitis Media

• Dose: 50 mg/kg as a single IM dose
• For 16.42 kg: 821 mg (approximately 1 gram)
• Maximum: 1 gram (single dose)
• This is a one-time treatment, not daily dosing

Serious Infections (Non-Meningitis)

• Dose: 50-75 mg/kg divided every 12 hours
• For 16.42 kg: 821-1,231 mg total daily, given as 410-615 mg every 12 hours
• Maximum: 2 grams/day

Meningitis

• Initial dose: 100 mg/kg (not to exceed 4 grams)
• For 16.42 kg: 1,642 mg (approximately 1.6 grams) as initial dose
• Maintenance: 100 mg/kg/day once daily or divided every 12 hours
• Maximum: 4 grams/day
• Duration: 7-14 days

Practical Reconstitution

For IM administration, reconstitute according to FDA guidelines 111:

• 500 mg vial: Add 1.8 mL diluent → yields 250 mg/mL concentration
• 1 gram vial: Add 3.6 mL diluent → yields 250 mg/mL concentration

Inject deep into a large muscle mass with aspiration to avoid intravascular injection.

Clinical Evidence Supporting Once-Daily Dosing

Research demonstrates that once-daily IM ceftriaxone is highly effective for outpatient treatment of serious pediatric infections. A prospective study of 74 children using 75 mg/kg initial dose followed by 50 mg/kg daily achieved 97% cure rate with improvement typically within 24 hours 2. Another study of 147 children with severe community-acquired pneumonia showed 96.6% cure rate with once-daily dosing, allowing 82% to be discharged after 48 hours 3.

The pharmacokinetic profile supports once-daily dosing: ceftriaxone has a prolonged half-life of 15.4 hours in neonates 4 and 6-8 hours in older children, maintaining therapeutic concentrations throughout a 24-hour dosing interval.

Critical Safety Considerations

Avoid in Specific Situations

• Do NOT use calcium-containing diluents (Ringer's, Hartmann's solution) for reconstitution 111
• Contraindicated in neonates ≤28 days receiving IV calcium-containing solutions
• Caution in hyperbilirubinemic neonates (though this patient at 16.42 kg is beyond neonatal age)

Monitoring

While generally safe, be aware that ceftriaxone can cause immune hemolytic anemia (direct antiglobulin test positive in 93% of cases when it occurs), though mortality has declined from 80% (1991-2000) to 18% in recent years with early recognition 5.

Dosing Pitfalls to Avoid

1. Don't underdose serious infections: Use the higher end (75 mg/kg) for severe infections, not the lower end
2. Don't confuse single-dose otitis media treatment (50 mg/kg once) with daily dosing regimens
3. Don't exceed maximum doses: 2 grams for most infections, 4 grams only for meningitis
4. Don't use twice-daily dosing for meningitis: Recent pharmacokinetic modeling shows 100 mg/kg once daily achieves better CSF penetration (88% PTA) compared to 50 mg/kg twice daily (53% PTA) 6

For this 16.42 kg patient, the most common scenario would be 1 gram IM once daily for standard serious infections, adjusting based on specific indication as outlined above.